Quantitative assessment of dynamic


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 2 11 2018
medline: 9 2 2019
entrez: 2 11 2018
Statut: ppublish

Résumé

To describe dynamic 41 consenting patients who underwent prostate DCE MR and dPET were included in this institutionally approved study. Intraprostatic lesions on MR were assigned a PI-RADS v2 score, and focal lesions on PET were documented. All lesions were correlated with pathology. Quantitative and semi-quantitative DCE MR and two-tissue compartmental model dPET parameters were determined and tumor-to-normal gland ratios (T/N) for these parameters were calculated. Finally, dPET and DCE MR correlation was estimated using Spearman correlation coefficients. There were 46 malignant lesions per standard of reference. On dPET, peripheral zone (PZ) tumors had higher K1 (p < 0.001), and a T/N ratio ≥2 was significant (p < 0.001). On DCE MR, the parameters in, kep, Ktrans and quantitative iAUC were higher for PZ and non-PZ tumors than corresponding normal tissue (p < 0.001); for PZ tumors, a T/N ratio ≥ 1.5 for Ktrans and pei was significant (p = 0.0019 and 0.0026, respectively). Moderate Spearman correlation (0.40 < ρ < 0.59) was found between dPET K1 and DCE MR Ktrans and pei. In patients with high-risk PCa, quantitative dPET and DCE-MR parameters in primary tumors differ from normal tissue. Only moderate correlation exists between K1 (dPET) and Ktrans and pei (DCE MR). The incremental value of any of these parameters to PI-RADS v2 warrants further investigation. Unique quantitative and semi-quantitative FCH PET/MR parameters in PCa differ from normal gland, and should be further investigated to determine their potential contribution to PI-RADS v2 in the detection of clinically significant PCa.

Identifiants

pubmed: 30383459
doi: 10.1259/bjr.20180568
pmc: PMC6404848
doi:

Substances chimiques

Contrast Media 0
Fluorine Radioisotopes 0
Radiopharmaceuticals 0
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20180568

Références

J Magn Reson Imaging. 1999 Sep;10(3):223-32
pubmed: 10508281
Cancer Res. 2001 Jan 1;61(1):110-7
pubmed: 11196147
J Cereb Blood Flow Metab. 2001 Jun;21(6):635-52
pubmed: 11488533
J Nucl Med. 2001 Dec;42(12):1805-14
pubmed: 11752077
J Nucl Med. 2002 Jan;43(1):92-6
pubmed: 11801711
J Nucl Med. 2002 Feb;43(2):187-99
pubmed: 11850483
Biochem Biophys Res Commun. 2002 Aug 23;296(3):580-3
pubmed: 12176020
Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):317-24
pubmed: 14628097
Radiology. 2005 May;235(2):623-8
pubmed: 15858102
AJR Am J Roentgenol. 2007 Oct;189(4):849
pubmed: 17885055
Phys Med Biol. 2008 Mar 7;53(5):1225-39
pubmed: 18296759
Radiology. 2010 Mar;254(3):925-33
pubmed: 20177103
Radiology. 2010 May;255(2):485-94
pubmed: 20413761
Magn Reson Med. 1991 Feb;17(2):357-67
pubmed: 2062210
J Nucl Med. 2011 Dec;52(12):1914-22
pubmed: 22080447
AJR Am J Roentgenol. 2012 Jun;198(6):1277-88
pubmed: 22623539
Eur Urol. 2013 Sep;64(3):448-55
pubmed: 23751135
Eur J Radiol. 2014 Aug;83(8):1363-7
pubmed: 24894697
Eur Urol. 2015 Dec;68(6):1045-53
pubmed: 25656808
J Nucl Med. 2015 Mar;56(3):365-71
pubmed: 25678491
Eur Radiol. 2016 Jun;26(6):1606-12
pubmed: 26396111
Radiology. 2015 Dec;277(3):826-32
pubmed: 26509226
Magn Reson Imaging. 2016 May;34(4):496-501
pubmed: 26708031
J Nucl Med. 2016 Mar;57(3):361-6
pubmed: 26769863
Radiology. 2016 Sep;280(3):793-804
pubmed: 27035179
Radiology. 2017 Feb;282(2):429-436
pubmed: 27513849
Clin Radiol. 2017 Jan;72(1):23-32
pubmed: 27726850
Eur J Radiol. 2016 Nov;85(11):2119-2126
pubmed: 27776667
Radiology. 2017 Apr;283(1):119-129
pubmed: 27783538
Medicine (Baltimore). 2016 Dec;95(52):e5715
pubmed: 28033274
EJNMMI Res. 2017 Dec;7(1):25
pubmed: 28324340
Br J Cancer. 2017 Apr 25;116(9):1159-1165
pubmed: 28350785
Acad Radiol. 2017 Sep;24(9):1101-1106
pubmed: 28546032
AJR Am J Roentgenol. 2017 Oct;209(4):800-805
pubmed: 28705064
J Urol. 2017 Dec;198(6):1301-1308
pubmed: 28709889
Eur J Radiol. 2017 Sep;94:154-159
pubmed: 28712703
Med Phys. 1995 Jul;22(7):1127-39
pubmed: 7565388
J Nucl Med. 1998 Jun;39(6):990-5
pubmed: 9627331

Auteurs

Noam Tau (N)

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , Toronto, ON , Canada.

Alejandro Berlin (A)

2 Department of Radiation Oncology, University of Toronto and Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network , Toronto, ON , Canada.

Ivan Yeung (I)

2 Department of Radiation Oncology, University of Toronto and Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network , Toronto, ON , Canada.

Jaydeep Halankar (J)

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , Toronto, ON , Canada.

Grainne Murphy (G)

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , Toronto, ON , Canada.

Kartik S Jhaveri (KS)

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , Toronto, ON , Canada.

Sangeet Ghai (S)

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , Toronto, ON , Canada.

Ur Metser (U)

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , Toronto, ON , Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH